First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2004-12-09 14:03:52Open Document File Size: 33,98 KBShare Result on FacebookCityBerlin / /CompanyBETAH Associates Inc. / Disease Registry / Agency for Toxic Substances / /CountryGermany / Austria / United States / Canada / Australia / Sweden / Denmark / /FacilityNational Library of Medicine / Institute of Medicine / /IndustryTermnatural gas / /MarketIndexBiological Exposure / /MedicalConditionAlzheimer’s disease / Bruxism / headache / kidney disease / nausea / allergy / tumor necrosis / injury / pulmonary dysfunction / delayed hypersensitivity / autoimmune disease / Parkinson’s disease / multiple sclerosis / hypersensitivity / neurodegenerative diseases / dizziness / renal dysfunction / /MedicalTreatmentchelation therapy / /OrganizationNational Health and Medical Research Council / Dental Material Commission of Sweden / U.S. Department of Health and Human Services / National Research Council / World Health Organization / Commission of the European Union Ad Hoc Working Group / office of the Chief Dental / Center for Devices and Radiological Health / U.S. Food and Drug Administration / Institute of Medicine / U.S. Environmental Protection Agency / European Commission / Public Health Service / Agency for Toxic Substances and Disease Registry / Expert Panel / Ministry of Health / Life Sciences Research Office / Centers for Disease Control and Prevention / /PositionDENTAL AMALGAM EXECUTIVE / General / Officer / /Productnicotine / /ProvinceOrStateQuebec / /Technologypharmacokinetics / PDF / /URLWWW.LSRO.ORG / /SocialTag |